Scientific Sessions 2025  /  When the Left Heart Goes Bad: Pulmonary Hypertension Due to Left Heart Disease  /  Debate - Most Patients With CpcPH and RV Dysfunction Should NOT Receive PAH-Targeted Therapies
Logo

American Heart Association

  30
  0

Final ID:

Debate - Most Patients With CpcPH and RV Dysfunction Should NOT Receive PAH-Targeted Therapies

  • Maron, Brad  ( University of Maryland , Sharon , Massachusetts , United States )
  • Gomberg-maitland, Mardi  ( GWMFA- George Washington University , Washington DC , District of Columbia , United States )
  • Hemnes, Anna  ( VANDERBILT UNIVERSITY , Nashville , Tennessee , United States )
  • De Marco, Teresa  ( University of California, , San Francisco , California , United States )
    • Author Disclosures:
    Brad Maron: DO NOT have relevant financial relationships | Mardi Gomberg-Maitland: DO NOT have relevant financial relationships | Anna Hemnes: DO have relevant financial relationships ; Consultant:gossamerbio:Active (exists now) ; Consultant:Johnson and Johnson:Past (completed) ; Individual Stocks/Stock Options:Tenax Therapeutics:Active (exists now) ; Consultant:united therapeutics:Past (completed) ; Consultant:merck:Active (exists now) | Teresa De Marco: DO have relevant financial relationships ; Consultant:Johnson & Johnson, Jansen:Active (exists now) ; Consultant:Aerovate:Past (completed) ; Advisor:Kamada:Past (completed) ; Consultant:Eidos:Active (exists now) ; Consultant:Keros:Past (completed) ; Research Funding (PI or named investigator):CareDx:Active (exists now) ; Consultant:Alexxion:Active (exists now) ; Advisor:Corsair:Active (exists now) ; Consultant:Pulnovo:Active (exists now) ; Consultant:United Therapeutics:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) ; Consultant:Merck:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

When the Left Heart Goes Bad: Pulmonary Hypertension Due to Left Heart Disease

Monday, 11/10/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Beyond HFpEF: PH in Other Cardiomyopathies

Rosenkranz Stephan, Maron Brad, Simon Marc

PH in HFpEF: A Rapidly Increasing Demographic

Sarma Satyam, Reddy Yogesh, Redfield Margaret

More abstracts from these authors:
Panel Discussion

Maron Brad

Opening the Medicine Cabinet: Current Therapeutic Strategies for PAH

Gomberg-maitland Mardi, Airhart Sophia, Chin Kelly

You have to be authorized to contact abstract author. Please, Login
Not Available